Skip to the page

Data / Drug companies / Micro Labs Limited

Micro Labs Limited: 154 products in the FDA NDC directory, labeler code 42571

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Micro Labs Limited (labeler code 42571) lists 154 products in the FDA National Drug Code Directory, covering 73 finished drugs by generic name. By type: 128 prescription drugs, 25 bulk ingredients. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 1, 2026.

The request: Watch Micro Labs Limited (FDA labeler code 42571): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
42571
Products in commercial distribution
154
Packages
353
Finished drugs by generic name
73
Prescription products
128
Over the counter products
1
Controlled substance products
Schedule IV 6, Schedule V 1
Flagged as original packager
103 of 103 products that carry the flag
Started marketing in the last 12 months
38
Earliest marketing start
November 19, 2010
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)12983.8%
Bulk ingredients2516.2%

Products by type

TypeProductsShare
Prescription drugs12883.1%
Bulk ingredients2516.2%
Over the counter drugs10.6%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Glimepiride632
Celecoxib463
Amlodipine and olmesartan medoxomil410
Dapagliflozin and metformin hydrochloride410
Amoxicillin and clavulanate potassium335
Clindamycin hydrochloride334
Furosemide363
Varenicline tartrate323
Olmesartan medoxomil and hydrocholorothiazide31
Clomipramine hydrochloride317
Diphenhydramine hydrochloride3127
Metformin hydrochloride379
Dapagliflozin226
Caffeine citrate28
Rufinamide212
Timolol maleate ophthalmic21
Amoxicillin235
Isoproterenol hydrochloride213
Tranexamic acid239
Pirfenidone226
Midazolam26
Roflumilast217
Brimonidine tartrate215
Diclofenac sodium/misoprostol23
Piroxicam212
Rasagiline211
Clobazam218
Tofacitinib223
Levocetirizine dihydrochloride252
Sapropterin dihydrochloride210
Methazolamide210
Bisoprolol fumarate225
Acetazolamide extended-release12
Dexamethasone sodium phosphate125
Latanoprost115
Nevirapine16
Ticagrelore11
Nicardipine hydrochloride127
Cholestyramine114
Mefenamic acid15
Carboprost tromethamine122
Ofloxacin ophthalmic11
Dorzolamide hydrochloride and timolol maleate111
Aspirin and extended-release dipyridamole14
Methenamine hippurate112
Chlordiazepoxide hcl and clidinium bromide12
Valganciclovir114
Bimatoprost115
Travoprost ophthalmic solution15
Ketorolac tromethamine169
Brivaracetam117
Nitrofurantoin128
Formoterol fumarate17
Dalfampridine111
Colchicine134
Tobramycin solution11
Proparacaine hydrochloride110
Cromolyn sodium111
Ticagrelor132
Sodium nitroprusside114
Verapamil hydrochloride146
Triamcinolone acetonide177
Timolol maleate120
Dorzolamide hydrochloride111
Rivaroxaban124
Famotidine1138
Arformoterol tartrate112
Tafluprost opthalmic11
Levetiracetam187
Succinylcholine chloride127
Clobetasol propionate140
Lincomycin13
Ramelteon129

Dosage forms

Dosage formProductsShare
Tablet2918.8%
Powder2516.2%
Tablet, film coated2214.3%
Capsule1912.3%
Injection149.1%
Solution/ drops127.8%
Solution85.2%
Injection, solution85.2%
Tablet, film coated, extended release63.9%
Powder, for solution31.9%
Powder, for suspension21.3%
Capsule, extended release10.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ticagrelor42571-293Tablet, film coatedGeneric drugs (ANDA)November 1, 2026
Ticagrelor42571-263Tablet, film coatedGeneric drugs (ANDA)November 1, 2026
Ofloxacin42571-461SolutionGeneric drugs (ANDA)October 15, 2026
OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE42571-206Tablet, film coatedGeneric drugs (ANDA)October 15, 2026
OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE42571-205Tablet, film coatedGeneric drugs (ANDA)October 15, 2026
OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE42571-204Tablet, film coatedGeneric drugs (ANDA)October 15, 2026
Dapagliflozin and Metformin Hydrochloride42571-323Tablet, film coated, extended releaseGeneric drugs (ANDA)October 1, 2026
Dapagliflozin and Metformin Hydrochloride42571-322Tablet, film coated, extended releaseGeneric drugs (ANDA)October 1, 2026
Dapagliflozin and Metformin Hydrochloride42571-321Tablet, film coated, extended releaseGeneric drugs (ANDA)October 1, 2026
Dapagliflozin and Metformin Hydrochloride42571-320Tablet, film coated, extended releaseGeneric drugs (ANDA)October 1, 2026
Dapagliflozin42571-318TabletGeneric drugs (ANDA)October 1, 2026
Dapagliflozin42571-317TabletGeneric drugs (ANDA)October 1, 2026
Rivaroxaban42571-345TabletGeneric drugs (ANDA)July 6, 2026
Brimonidine tartrate42571-462Solution/ dropsGeneric drugs (ANDA)July 1, 2026
Tofacitinib42571-377Tablet, film coatedGeneric drugs (ANDA)June 8, 2026
Tofacitinib42571-268Tablet, film coatedGeneric drugs (ANDA)June 3, 2026
Valganciclovir42571-477Powder, for solutionGeneric drugs (ANDA)June 1, 2026
Bisoprolol42571-471Tablet, film coatedGeneric drugs (ANDA)June 1, 2026
Bisoprolol42571-470Tablet, film coatedGeneric drugs (ANDA)June 1, 2026
Sapropterin Dihydrochloride42571-510Powder, for solutionGeneric drugs (ANDA)April 1, 2026
Sapropterin Dihydrochloride42571-509Powder, for solutionGeneric drugs (ANDA)April 1, 2026
Cholestyramine42571-508Powder, for suspensionGeneric drugs (ANDA)April 1, 2026
Furosemide42571-438InjectionGeneric drugs (ANDA)March 1, 2026
Furosemide42571-437InjectionGeneric drugs (ANDA)March 1, 2026
Furosemide42571-436InjectionGeneric drugs (ANDA)March 1, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.